Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharm > Drugs Affecting the Cardiovascular System > Flashcards

Drugs Affecting the Cardiovascular System Flashcards

1
Q

Heart does not adequately pump blood (systolic) or fill with blood (diastolic)
Preload / Afterload / Contractility - meds target diff aspects of heart

A

Review patho: HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inability/heart unable to meet metabolic (oxygen) demands of the body - not able push blood through body well enough
Right ventricular failure, left ventricular failure, congestive failure

A

Heart does not adequately pump blood (systolic) or fill with blood (diastolic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Increased preload (blood volume heart receives) causes increased workload on heart
Increased afterload (big thing is PVR) increases workload on heart
Heart enlarges (with HF), but weakens, resulting in poor contraction (contractility - strength heart with each beat)

A

Preload / Afterload / Contractility - meds target diff aspects of heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Reduce preload: Furosemide (diuretic), lisinopril

A

Increased preload (blood volume heart receives) causes increased workload on heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Reduce afterload (vascular resistance): metoprolol, lisinopril

A

Increased afterload (big thing is PVR) increases workload on heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Increase contractility: digoxin (Lanoxin)

A

Heart enlarges (with HF), but weakens, resulting in poor contraction (contractility - strength heart with each beat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Increases force of contraction, increasing cardiac output and renal perfusion; slows HR (end goal: slower but more powerful heart - each beat heart is stronger)

A

MoA: - Cardiac glycoside: prototype: digoxin (Lanoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

treat Heart failure

A

Indication: - Cardiac glycoside: prototype: digoxin (Lanoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

oral, IV (IV push over at least 5 minutes with tele monitor - risk for bradycardia); IV: higher risk for AE

A

Routes: - Cardiac glycoside: prototype: digoxin (Lanoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Amiodarone and other antidysrhythmic drugs

A

Drug-drug: - Cardiac glycoside: prototype: digoxin (Lanoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

heart block (bradycardia and digoxin can cause bradycardia which why not want give if HR already slow), decreased renal function

A

Caution: - Cardiac glycoside: prototype: digoxin (Lanoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

GI effects, visual disturbances (green/yellow halo), arrhythmias (bradycardia)

A

AE: - Cardiac glycoside: prototype: digoxin (Lanoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

take apical pulse 1 full min prior to admin. (adequate HR to admin) Hold if HR less than 60 –notify provider - diff bradycardias and have HF and perfusion and BP goes way down - adequately count HR before given; use same brand consistently- diff brands have varied bioavailability (amt drug avaiable work in bloodstream); Toxicity rare but serious – monitor blood levels q 3 months, narrow therapeutic range

A

Nursing: - Cardiac glycoside: prototype: digoxin (Lanoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pretty rare
Manifestations:
Reversal agent:

A

Digoxin toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bradycardia - apparent
Headache
Dizziness
Confusion
Nausea/vomiting
Visual disturbances

A

Manifestations:- Digoxin toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Digoxin immune fab (creates antigen-antibody immunes complexes with drug – inactivates the drug)

A

Reversal agent:- Digoxin toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Atherosclerosis narrows coronary arteries: Stable and unstable plaques
Plaque rupture: Decreased blood flow; Decreased oxygen to cardiac tissue
Myocardial infarction: Tissue death

A

Coronary Artery Disease (CAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Chest pain with exertion
Increased O2 demand of heart
Relieved with rest and nitroglycerin

A

Stable angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Chest pain at rest
Unrelieved with nitroglycerin
Possible myocardial infarction

A

Unstable angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Relaxes vascular smooth muscle; dilates coronary arteries to increase blood flow to myocardial tissue - restores blood flow and O2

A

MoA: - Antianginal Agents: Prototype: nitroglycerin (Nitrostat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Acute angina - given if experiencing angina; relief for angina; restores blood flow to heart tissue; short term solution to MI

A

Indication: - Antianginal Agents: Prototype: nitroglycerin (Nitrostat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Sublingual tablet (works quickly to resolve prob and restore flow; bypass first pass effect so directly into system and acts quickly) q 5 min up to 3 doses; onset: 1-3 min; dur.: 30-60 min

A

Route: - Antianginal Agents: Prototype: nitroglycerin (Nitrostat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

erectile dysfunction meds in last 24 hrs (sildenafil/Viagra - causes hypotension - taking together causes unsafe drop in BP)

A

Caution: - Antianginal Agents: Prototype: nitroglycerin (Nitrostat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

hypotension (relaxes vessels all over body; sig), headache, lightheaded and experience dizziness, tachycardia, sweating

A

Adverse effects: - Antianginal Agents: Prototype: nitroglycerin (Nitrostat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

May administer 1 dose every 5 minutes up to 3 doses - imp keep track time; give enough time work before give extra doses
If no relief after 2nd dose after 5 min, assume MI/cardiac event and call rapid response team and decide where to go
Monitor blood pressure after administration - check BP 3-5 min later; if trend low can deviate and difference in what do; hypotensive increased risk for falls take additional actions
High fall risk - may need lay them down; vasodilation

A

Nursing actions in acute care - Nitro: nursing and teaching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Administration as above (after 2nd dose call 911): May administer 1 dose every 5 minutes up to 3 doses - keep track time; enough time work before give extra doses; If no relief after 2nd dose after 5 min, assume MI/cardiac event and call 911
Med must be stored in a dry, dark place – exposed to sunlight decompose and alter med - keep in dark glass container; need med to work when need it
Refill medication when it is near expiration/expires

A

Teaching - Nitro: nursing and teaching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

The nurse would instruct a client taking digoxin to do which of the following?
A.Make up a missed dose the next day
B.Report changes in heart rate
C.Avoid exposure to the sun
D.Switch to another brand if less expensive

A

Answer: B
Rationale: Digoxin can cause arrhythmias (bradycardia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

The nurse is preparing to administer digoxin to a client with an apical pulse of 48 beats per minute. What action should the nurse take next?
A.Give the drug and notify the primary care provider that the heart rate is low.
B.Retake the pulse in 15 minutes and give the drug if the heart rate is unchanged.
C.Retake the pulse in 1 hour and hold the drug if the heart rate is unchanged.
D.Hold the drug and notify the primary care provider that the heart rate is below 60 beats per minute.

A

Answer: D
Rationale: The best action is to hold the dose and notify the provider. Digoxin cannot be safely given to a patient who is bradycardic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the mechanism of action of nitroglycerin?
A.Increase preload on the heart.
B. Increase the afterload on the heart.
C. Dilate coronary arteries.
D. Decrease fluid volume.

A

Answer: C
Rationale: Nitroglycerin dilates the coronary arteries to increase blood flow and therefore oxygenation to tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Changes to automaticity or conductivity of heart cells: Change in HR
Uncoordinated heart muscle contractions
Altered movement of impulses
Atrial fibrillation
Tachycardias

A

Review patho: arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Dyssynchronous firing of atria
Uncoordinated with ventricles
Most common arrhythmia
Acute and chronic
Slow HR: Metoprolol, diltiazem, amiodarone

A

Atrial fibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Ventricular fibrillation
Ventricular tachycardia
Medical emergencies
Controls V arrhythmia- Lidocaine

A

Tachycardias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Delineate into classes
Antiarrythmic drug
Class I: Na channel blockers
Class II: beta-adrenergic blockers
Class III: K channel blockers
Class IV: Ca channel blockers

A

Antidysrhythmic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

IV Lidocaine
Life-threatening ventricular arrhythmias during MI/cardiac surgery

A

Class I: Na channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Metoprolol
afib/flutter
Suprventricular and ventricular dysrhythmia
HTN

A

Class II: beta-adrenergic blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Amiodarone
afib/flutter
vtach/fib

A

Class III: K channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Diltiazem
Supraventricular tachycardias
afib/flutter
HTN

A

Class IV: Ca channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Altering action potentials: All have potential adverse effects:
Drug-drug:
Contraindications:

A

Antidysrhythmic drugs: gen considerations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Bradycardia, heart blocks, arrhythmias, and hypotension (all can cause low HR, slow down HR lower BP at same time because decreasing CO)
Probs at Greater risk with IV administration
With IV: need be on Tele monitor (monitor rhythm closely), closely monitor BP (arterial line/cuff and check BP frequently)

A

Altering action potentials: All have potential adverse effects:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Two Antidysrhythmic drugs together (dangerous - sig increased risk of bradycardia), antihypertensives (lower HR and on these sig impact CO which lowers and on this lowers BP so can get too low BP)

A

Drug-drug:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Bradycardia (potentially lower HR), hypotension (potentially lower BP), heart block (lack of cardiac conduction somewhere in part cardiac tissue; diff grades and some more severe than others; type of bradycardia) - not give if already have low BP/HR because would drop them more

A

Contraindications:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Treatment of life-threatening ventricular arrhythmias during MI or cardiac surgery; small use for IV

A

Indication: - Sodium Channel Blockers: Prototype: Lidocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

IV (topical lidocaine low risk systemic) - dangerous drug; POTENT

A

Routes: - Sodium Channel Blockers: Prototype: Lidocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

IV-immediate; Peak: IV-Immediate; Duration: IV-20 min

A

Onset: - Sodium Channel Blockers: Prototype: Lidocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Dizziness, headache, cardiac arrest, respiratory depression, anaphylaxis

A

AE: - Sodium Channel Blockers: Prototype: Lidocaine

46
Q

Have resuscitation equipment available potentially cause cardiac arrest - sig bradycardia

A

Nursing: - Sodium Channel Blockers: Prototype: Lidocaine

47
Q

Blocks potassium channels, delays repolarization; slows HR

A

MoA: - Potassium Channel Blockers: Prototype: Amiodarone

48
Q

v-tachycardia and v-fibrillation - lifethreatening - given IV push and ACLS; chronic Atrial fib or flutter; used in variety ways

A

Indications: - Potassium Channel Blockers: Prototype: Amiodarone

49
Q

Maintenance for chronic afib: oral scheduled - goal: HR less than 110 - too high lose CO; Acute: treat vtach/fib/afib with RVR (infusion; can give loading dose) - loading dose then switched over when appropriate: IV push/infusion/drip on tele floors/ICU/ER/ACLS (adv care life support)

A

Dose: - Potassium Channel Blockers: Prototype: Amiodarone

50
Q

Increase digoxin levels (up to 50-70% - issue since has narrow therapeutic window - toxic on med); decreases metabolism of warfarin requiring lower doses - more left in bloodstream so higher risk for bleeding (up to 50% increase in INR); if taken with this drug decreases doses of either drug by 50%

A

Drug-Drug: - Potassium Channel Blockers: Prototype: Amiodarone

51
Q

GI effects (n/v/d), corneal microdeposits (photophobia, visual halos, dry eyes) - long term: higher risk to develop, fatigue, dizziness, photosensitivity; highly lipophilic drug: VERY attracted fat tissues

A

AE: - Potassium Channel Blockers: Prototype: Amiodarone

52
Q

Hepatotoxicity, pulmonary toxicity, pro-arrhythmias

A

Black box: - Potassium Channel Blockers: Prototype: Amiodarone

53
Q

Teach - no grapefruit juice (liver enzyme interaction and not metabolize so more in bloodstream), use barrier sunblock (photosensitivity - barrier sunblocks; avoid sun); tele monitoring (if getting IV - closely monitor rhythm), monitor electrolytes

A

Nursing: - Potassium Channel Blockers: Prototype: Amiodarone

54
Q

A client who is taking an antiarrhythmic drug will need which of the following?
A.Constant cardiac monitoring until stabilized.
B.Frequent blood tests including blood levels.
C.An antidepressant to combat the adverse effect of depression.
D.Dietary changes to prevent irritation of the heart muscle.

A

Answer: A
Rationale: If a patient is unstable, they will likely need an IV antidysrhythmic medication which requires cardiac monitoring.

55
Q

Decrease PVR
Normal blood pressure = CO + SVR (aka PVR)
Decrease blood volume

56
Q

Beta-blockers (SNS)
Calcium-channel blockers
Direct vasodilators
ACE-Inhibitors
ARB’s

A

Decrease PVR

57
Q

ACE-Inhibitors
ARB’s
Diuretics

A

Decrease blood volume

58
Q

Lisinopril: ACE inhibitor; inhibiting ACE being able convert angiotensin I to angiotensin II - blocking part cascade of RAAS - cannot have vasoconstriction/aldosterone release
Losartan: angiotensin receptor blocker; blocks receptor sites for angiotensin II - cannot exert actions
Blocking RAAS: end up with not vasoconstrict as well (decreases PVR) and not release as much aldosterone and then reabsorb less Na and H2O decreasing blood volume

A

Review BP/RAAS

59
Q

Uncontrolled hypertension can cause which of the following problems? Select all that apply.
A.Loss of vision
B.Stroke
C.Acceleration of atherosclerosis
D.Kidney disease
E.Diabetes mellitus type 2

A

Answer: A, B, C, D
Rationale: Uncontrolled hypertension can accelerate atherosclerosis and cardiovascular disease. Diabetes can contribute to worsening hypertension, but it is hypertension does not cause diabetes.

60
Q

Angiotensin converting enzyme (ACE) inhibitor
Angiotensin receptor blocker (ARB)
Calcium-channel blocker
Vasodilator
Thiazide diuretics

A

Antihypertensive drugs (all treat HTN)

61
Q

-pril
Blocks ACE, the enzyme responsible for converting angiotensin I to angiotensin II in the lungs; prevents vasoconstriction and aldosterone release (RAAS)

A

Angiotensin converting enzyme (ACE) inhibitor

62
Q

-sartan
Blocks binding to specific receptors in the blood vessels and adrenal gland; prevents vasoconstriction and aldosterone release (RAAS)

A

Angiotensin receptor blocker (ARB)

63
Q

Diltiazem (Cardizem); Amlodipine
-pine
Inhibit the movement of Ca ions across the membranes of myocardial and arterial muscle cells blocking muscle cell contraction - slow down HR and BP - antiarrhythmic/antihypertensive; decrease BP, cardiac workload, and myocardial O2 consumption

A

Calcium-channel blocker

64
Q

Nitroprusside; Hydralazine
Act directly on vascular smooth muscle to cause relaxation

A

Vasodilator

65
Q

-thiazide
Increase Na and water excretion from the kidney; first line treatment for HTN; get rid more blood volume via water decreasing BP

A

Thiazide diuretics

66
Q

-olol
Block vasoconstriction, decrease HR, decrease cardiac muscle contraction, increase blood flow to the kidneys (block beta 1 and beta 2 receptors - activated affect BP; normal action increase HR and BP) - block less vasoconstriction and slower HR

A

Beta adrenergic blocker - Antihypertensive drugs: adrenergic blocking agents

67
Q

Take BP prior to admin! (all can cause hypotension - primary AE - given too much; need know where start)
If dosed once daily, give in the AM - BP much higher in day when doing things than HS - most help to control BP, esp for diuretic
Do not abruptly discontinue (esp. Beta adrenergic blocking agents)
IV push medications
PRN medications require evaluation

A

Administration Considerations for Antihypertensive Drugs (Acute Care)

68
Q

Do NOT split, crush or chew extended-release tablets (ER, XL)

A

If dosed once daily, give in the AM - BP much higher in day when doing things than HS - most help to control BP, esp for diuretic

69
Q

Once taken away body goes into overdrive
Risk for reflex HTN - can get really high BP

A

Do not abruptly discontinue (esp. Beta adrenergic blocking agents)

70
Q

Administer over a minimum of 2 minutes - not want too quick to drop BP; Telemetry monitor: some can affect HR and BP

A

IV push medications

71
Q

IVP: recheck BP in 5-10 min to make sure coming down way want
PO: recheck BP in 1 hour

A

PRN medications require evaluation

72
Q

Blocks ACE, the enzyme responsible for converting angiotensin I to angiotensin II in the lungs; decreases vascular resistance, prevents aldosterone secretion, prevents breakdown of bradykinin (potent vasoconstrictor)

A

MoA: - ACE-Inhibitor: Prototype: lisinopril

73
Q

ACE-inhibitors, ARB’s, K+ sparing-diuretics, NSAIDs (toxic to kidneys)

A

Contra/Caution: - ACE-Inhibitor: Prototype: lisinopril

74
Q

Common-Persistent dry cough (annoying and decrease compliance if cont have it), orthostatic hypotension, hyperkalemia; Rare-angioedema

A

AE: - ACE-Inhibitor: Prototype: lisinopril

75
Q

monitor K+ (increase K levels), renal function - toxic to kidneys overtime

A

Nursing: - ACE-Inhibitor: Prototype: lisinopril

76
Q

A = Angioedema
C = Cough
E = Elevated potassium

A

ACE acronym for AE (of ACE-I)

77
Q

Blocks binding of angiotensin II to specific receptors in blood vessels and adrenal gland; used as alternate to ACE-inhibitors

A

MoA: - Angiotensin-receptor blocker (ARB): Prototype: losartan (Cozaar)

78
Q

ACE-inhibitors, ARB’s, K+ sparing-diuretics, NSAIDs (toxic to kidneys)

A

Contra/Cautions: - Angiotensin-receptor blocker (ARB): Prototype: losartan (Cozaar)

79
Q

GI effects (n/v/d)

A

AE: - Angiotensin-receptor blocker (ARB): Prototype: losartan (Cozaar)

80
Q

Act directly on vascular smooth muscle (venous and arterial) to cause relaxation/vasodilation; persistent HTN hard treat

A

MoA: - Direct Vasodilator: Prototype: nitroprusside (Nitropress)

81
Q

Maintenance: oral or transdermal; Acute HTN crisis: IV push

A

Route: - Direct Vasodilator: Prototype: nitroprusside (Nitropress)

82
Q

PVD (veins already dilated), CAD, HF (more sig hypotension and not adequately perfuse because low CO), tachycardia, hypotension

A

Caution: - Direct Vasodilator: Prototype: nitroprusside (Nitropress)

83
Q

Hypotension (sig vasodilation), reflex tachycardia, bradycardia - cardiac monitor if IV

A

AE: - Direct Vasodilator: Prototype: nitroprusside (Nitropress)

84
Q

Inhibits flow of calcium ions into myocardial cells and vascular smooth muscle; slows HR, lowers BP

A

MoA: - Calcium-channel blocker: Prototype: diltiazem (Cardizem)

85
Q

HTN, A-fib, A-flutter, supraventricular tachycardias

A

Indication: - Calcium-channel blocker: Prototype: diltiazem (Cardizem)

86
Q

Maintenance (afib and HTN): oral ; acute (afib with RVR): IV infusion

A

Route: - Calcium-channel blocker: Prototype: diltiazem (Cardizem)

87
Q

hypotension, acute MI, pulmonary congestion

A

Caution: - Calcium-channel blocker: Prototype: diltiazem (Cardizem)

88
Q

Hypotension, bradycardia/heart block, peripheral edema - must monitor for; deals with relaxation of arteries and not change pressure of veins - fluid pushed out into peripheral tissues

A

AE: - Calcium-channel blocker: Prototype: diltiazem (Cardizem)

89
Q

teach- avoid grapefruit juice (increases levels)

A

Nursing: - Calcium-channel blocker: Prototype: diltiazem (Cardizem)

90
Q

Block beta-1 and beta-2 receptors of the SNS; slows HR and lowers BP

A

MoA: - Beta Adrenergic Blocker: Prototype: metoprolol (Toprol)

91
Q

HTN, Heart failure, s/p MI, A-fib/flutter, angina

A

Indications: - Beta Adrenergic Blocker: Prototype: metoprolol (Toprol)

92
Q

Maintenance (afib/HTN): oral; acute HTN or dysrhythmias: IV push

A

Route: - Beta Adrenergic Blocker: Prototype: metoprolol (Toprol)

93
Q

Beta-agonist inhaler (albuterol) - opposing MoA: trouble is albuterol less effective because metoprolol blocking receptors for albuterol

A

Drug-drug: - Beta Adrenergic Blocker: Prototype: metoprolol (Toprol)

94
Q

bradycardia, hypotension, masks signs of hypoglycemia - blocking SNS sites when tries activate cannot since blocking receptors so not same s/s so monitor BG closely

A

Contra/Cautions: - Beta Adrenergic Blocker: Prototype: metoprolol (Toprol)

95
Q

Bradycardia, hypotension, bronchospasm, pulmonary edema, weakness - blocking SNS, fatigue - blocking SNS, decreased exercise tolerance - good job keeping HR low so not exercise high level because keeps HR down, alterations in blood glucose

A

Adverse effects: - Beta Adrenergic Blocker: Prototype: metoprolol (Toprol)

96
Q

monitor hypoglycemia closely in diabetes mellitus - masking s/s; immediate and extended release (XL, XR) prescribed

A

Nursing: - Beta Adrenergic Blocker: Prototype: metoprolol (Toprol)

97
Q

Physical assessment with focus CV (#1 priority), respiratory, and neuro assessments
Labs: electrolytes (not in an imbalance), kidney, and liver function - track to ensure kidney func not worsening which happens with HTN
Assess cardiac rhythm (if on tele monitor - not induced secondary rhythm and in correct rhythm)
Best prac: Always assess HR and BP prior to administration in acute care since work together
Blood pressure parameters (general):
Heart rate parameters (general):

A

Care Plan for Antiarrhythmic and Antihypertensive Drugs: Assessment

98
Q

Will be Hold parameters

A

Best prac: Always assess HR and BP prior to administration in acute care since work together

99
Q

High: Greater than 180 SBP and/or 110 DBP &raquo_space;> Call MD - may need additional BP meds
Low: Less than 90 SBP and/or 60 DBP&raquo_space;> Hold and call MD

A

Blood pressure parameters (general):

100
Q

Hold if HR < 60 bpm

A

Heart rate parameters (general):

101
Q

Monitor cardiac rhythm closely with admin of IV antiarrhythmic agent
If appropriate Consult prescriber to switch from IV to oral if indicated ASAP - risk bradycardia and other AE much more likely - lot safer for pat
Educate client:

A

Nursing Care Plan: Antiarrhythmic Interventions

102
Q

Ensure emergency life support equipment readily available

A

Monitor cardiac rhythm closely with admin of IV antiarrhythmic agent

103
Q

Medication: dosing, timing, drug specific AE
Do not abruptly discontinue medication (pt will take scheduled) - risk developing comps
NEED TO DO THIS: How to assess pulse, blood pressure and s/s bradycardia and hypotension (fatigue, lightheadness, syncope, frequent falling)
Need for follow-up and monitoring
Periodically assess cardiac rhythm with oral agents (yearly as baseline to see how doing) - probs - do more often or go home on monitor

A

Educate client:

104
Q

Monitor for any situation which may lead to decreased fluid volume - much more hydrated when hot out - decreased fluid volume and risk hypotension; adequately hydrated all time and alert for any changes in fluid volume
Reduce risk for falls (risk for orthostatic hypotension)
Consult with prescriber to switch from IV to oral if indicated - minimize risk hypotension
Educate client:

A

Nursing Care Plan: Antihypertensive Interventions

105
Q

Lifestyle change - HTN - lower BP outside meds: weight loss, smoking cessation, decreased alcohol/salt intake
Medication: dosing, timing, drug specific AE
Do not abruptly discontinue (pt will take scheduled) - reflex HTN
NEED TO DO THIS: How to assess pulse, blood pressure and s/s bradycardia or hypotension
Educated on any Need for follow-up and monitoring: seen more often until stable

A

Educate client:

106
Q

Therapeutic response (depends on indication/MoA)
Adverse effects
Teaching (was it effective?)

A

Care Plan for Antiarrhythmic and Antihypertensive Drugs: Evaluation

107
Q

BP goal for most clients: SBP < 140 mm Hg, DBP < 90 mm Hg: Multiple antihypertensives may be needed to achieve target goal
HR goal for A-fib: < 110 bpm = COMMON: Caution: drug-drug interaction multiple meds that slow HR

A

Therapeutic response (depends on indication/MoA)

108
Q

Bradycardia (Antiarrhythmic), hypotension (Antihypertensive), drug specific

A

Adverse effects

109
Q

Safety and efficacy of meds not widely studied; most not need these meds; afib and HTN later in life because not taking very much

A

Children - Drug therapy across the lifespan: cardiac drugs

110
Q

Consider drug-drug interactions, co-morbidities; appropriate education

A

Adults - Drug therapy across the lifespan: cardiac drugs

111
Q

Many meds are Pregnancy Category D; consider risk vs. benefit

A

Pregnancy- Drug therapy across the lifespan: cardiac drugs

112
Q

More susceptible to AE of hypotension, bradycardia, toxic effects due to underlying disease that may interfere with metabolism and excretion
High fall risk - implement fall precautions
Monitor closely

A

Older Adults- Drug therapy across the lifespan: cardiac drugs

Pharm (30 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions